University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.
- The technology relies on inserting into cells pieces of carefully designed messenger RNA (mRNA), a strip of genetic material that human cells typically transcribe from a person’s DNA in order to make useful proteins and go about their business. Problems delivering mRNA safely and intact without running afoul of the immune system have held back mRNA-based therapy, but UW–Madison researchers are making tiny balls of minerals that appear to do the trick in mice.
- “These microparticles have pores on their surface that are on the nanometer scale that allow them to pick up and carry molecules like proteins or messenger RNA,” says William Murphy, a UW–Madison professor of biomedical engineering and orthopedics. “They mimic something commonly seen in archaeology, when we find intact protein or DNA on a bone sample or an eggshell from thousands of years ago. The mineral components helped to stabilize those molecules for all that time.”
- “What we’ve seen with the MCMs is, once the cells take up the mRNA and start making protein, that protein will bind right back within the MCM particle,” Murphy says. “Then it gets released over the course of weeks. We’re basically taking something that would normally last maybe hours or even a day, and we’re making it last for a long time.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate canceron September 30, 2020 at 11:17 am
Thus, prevalence of hm-cells is a prognosticator of poor outcome in prostate cancer, and a potentially predictive and therapy ... 3A is based on data for 54 of 56 patients due to missing clinical ...
- Moderna and Regeneron Gain on Positive Covid-19 Vaccine Trial Resultson September 30, 2020 at 8:28 am
Moderna and Regeneron gain alongside other Covid-19-focused vaccine developers after both companies reveale positive news about their respective vaccine trials.
- The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVacon September 30, 2020 at 4:45 am
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc ...
- Oncorus Finalizes $87 Million U.S. IPO Efforton September 29, 2020 at 1:03 am
Cambridge, Massachusetts-based Oncorus was founded to develop an ... and was previously Head of Oncology Development at Moderna (MRNA) Below is a brief overview video of oncolytic virotherapy ...
- Regulatory RNA Control with Lighton September 28, 2020 at 5:04 am
Within every cell resides a mechanism that ensures mRNA transcriptions are “shredded” after a short time. This ensures that protein is only produced as long as it is needed. Several decades ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Environmental science and pollution research internationalon October 1, 2020 at 5:00 pm
Indoor concentrations of PM2.5 and associated water-soluble and labile heavy metal fractions in workplaces: implications for inhalation health risk assessment.
- Professor Steven P. Armeson August 19, 2020 at 11:37 am
We prepare a broad range of microscopic conducting polymer-based particles, including conducting polymer-coated latexes, conducting polymer-silica nanocomposite particles and sterically-stabilised ...
- Peter Yang Publicationson December 28, 2018 at 10:40 am
Three substrates were used in this study: (1) succinimide-terminated PCL (PCL-NHS) as model material, (2)alkali-treated PCL (PCL-NaOH) as first control material, and (3) fibrin-coated PCL (PCL-Fibrin) ...
- Dr Gwendolen Reillyon April 29, 2018 at 7:19 pm
We are interested in how skeletal cells respond to extrinsic and intrinsic stimuli by organizing the proteins and mineral they secrete in a way ... polymer scaffolds and peptide coated surfaces (in ...
- Publications & Awardson April 18, 2016 at 10:05 am
Here, we propose a processing route in which Cu-coated ZnO powders are directly shaped into architectured electrodes using a simple uniaxial pressing step. Uniaxial pressing leads to a percolating Cu ...